Reply to J. Cabezas et al
J Clin Oncol
.
2016 Jan 20;34(3):290-1.
doi: 10.1200/JCO.2015.64.3064.
Epub 2015 Dec 7.
Authors
Jessica P Hwang
1
,
Mark R Somerfield
2
,
Devena E Alston-Johnson
3
,
Donna R Cryer
4
,
Jordan J Feld
5
,
Barnett S Kramer
6
,
Anita L Sabichi
7
,
Sandra L Wong
8
,
Andrew S Artz
9
Affiliations
1
The University of Texas MD Anderson Cancer Center, Houston, TX.
2
American Society of Clinical Oncology, Alexandria, VA guidelines@asco.org.
3
Upstate Oncology Associates, Greenville, SC.
4
Global Liver Institute, Washington, DC.
5
Toronto Western Hospital Liver Center, Toronto, Ontario, Canada.
6
National Cancer Institute, Bethesda, MD.
7
Baylor College of Medicine, Houston, TX.
8
University of Michigan, Ann Arbor, MI.
9
University of Chicago, Chicago, IL.
PMID:
26644541
DOI:
10.1200/JCO.2015.64.3064
No abstract available
Publication types
Letter
Comment
MeSH terms
Antineoplastic Agents / administration & dosage*
Hematopoietic Stem Cell Transplantation*
Hepatitis B, Chronic / diagnosis*
Humans
Neoplasms / drug therapy*
Virus Activation*
Substances
Antineoplastic Agents